As competition intensifies in the incretin field, robust preclinical models are becoming critical to accurately predict clinical efficacy and safety
Diabetes 67 , 11131127 (2018)
The BPC-157 Layer: Addresses the structural side (protecting the gut lining from the GI distress GLP-1s often cause, and potentially mitigating the severe muscle loss that accompanies rapid weight reduction)
Proton-pump inhibitors (e.g., omeprazole, esomeprazole, and lansoprazole), used to treat Zollinger-Ellison syndrome and gastroesophageal reflux disease (GERD), markedly decrease stomach acid secretion required for the release of vitamin B 12 from food but not from supplements
But its in conflict with the idea of a health insurance system that offers a minimum standard of coverage for low-income people. Last year, Novo Nordisk brought in nearly $30 billion in GLP-1 sales
Therapies to Address Cognitive Problems The aim of these treatments is to slow down the decline of cognitive function